Una piattaforma per l’analisi cinetica delle reti metaboliche su scala genomica.

2. PROBLEM & CONSEQUENCES
1 approved drug
drug discovery
preclinical phase
clinical trials
regulatory phase
30%
50%
20%
our solution is perfect to cut down both
costs and time of the drug discovery
and the preclinical phase
5000-10000 compounds
250 compounds
5-20 compounds

3. SOLUTION
Research necessity to
predict compounds’
effect on metabolic
networks
Our novel AI-based algorithms dramatically reduce the number of
parameters required for model simulations
LOWER COSTS
Reduces preliminary
and validation
experiments
FEWER ERRORS
Improves the
metabolic
target/biomarker
identification
BETTER ANALYSIS
Provides details on
the dynamics of the
entire system
Kinetic analysis of
genome-size models
is a possible solution

4. APPLICATIONS
Predicting the
effect of
environmental
perturbations or
genetic
mutations
Enhancing the
productivity of
industrial
products
💉
Generating new
biochemical
compounds
Designing new
metabolic
pathways or
improving
existing ones
💊 ⏣
NO MORE ONE-SIZE-FITS-ALL APPROACH
Treat diseases based upon a person’s unique genetic makeup,
lifestyle, habits and environment

5. MARKET
Growth
39%
EUROPEAN
BIOINFORMATIC SECTOR

6. COMPETITORS

7. FUTURE PERSPECTIVES

8. CUSTOMER SEGMENTS
SME
PRIVATE
COMPANIES
PUBLIC
INSTITUTIONS
Limited budget
Limited research field
Big budget &
resources
Research studies in
different fields
Variable budget
Huge amount of
research fields

9. REVENUE MODEL B2B
SME
PRIVATE
PUBLIC
Free €79/month €599/month
DEMO
Limit network size
Free reactions
No support
No limit network size
€0.10 per reaction
Standard support
No limit network size
€0.02 per reaction
Full support

10. MILESTONES

11. SWOT ANALYSIS
S
O
W
T
• Unique service
• Highly specific
• Lower computational
constraints
• Expanding market
• Advancement in machine
learning
• High demand for more
sophysticated prediction
models
• Forecasted world CAGR
13.85%
• Time-consuming MVP
• High entry barriers
• Imitability on case of no
protection of IPR
• Right timing for market
entrance

12. FINANCIALS
BREAK EVEN POINT
20 MONTHS

13. WHAT DO WE NEED
150.000€
MINIMUM 25K FOR 4% OWNERSHIP

14. TEAM

15. FOUNDER